Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins ; volume:8 ; number:1 ; day:28 ; month:8 ; year:2007 ; pages:1-9 ; date:12.2007
Trials ; 8, Heft 1 (28.8.2007), 1-9, 12.2007
- Beteiligte Personen und Organisationen
-
De Berardis, Giorgia
Sacco, Michele
Evangelista, Virgilio
Filippi, Alessandro
Giorda, Carlo B.
Tognoni, Gianni
Valentini, Umberto
Nicolucci, Antonio
SpringerLink (Online service)
- DOI
-
10.1186/1745-6215-8-21
- URN
-
urn:nbn:de:1111-2016050216341
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- De Berardis, Giorgia
- Sacco, Michele
- Evangelista, Virgilio
- Filippi, Alessandro
- Giorda, Carlo B.
- Tognoni, Gianni
- Valentini, Umberto
- Nicolucci, Antonio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
Aspirin for Prevention of Preeclampsia
The role of aspirin, statins, colchicine, and IL-1 inhibitors in prevention of cardiovascular events: a systematic integrative review
Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?
Harms and Benefits of Using Aspirin for Primary Prevention of Cardiovascular Disease: A Narrative Overview
Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Japanese Patients with Atherosclerotic Risk Factors: Subanalysis of a Randomized Clinical Trial (JPPP-70)
Prevention of cardiovascular diseases
Investigating the effectiveness of different aspirin dosing regimens and the timing of aspirin intake in primary and secondary prevention of cardiovascular disease: protocol for a systematic review
Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer
Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the Management of Aspirin-induced Gastrointestinal Complications (MAGIC) study
Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
Aspirin for Prevention of Preeclampsia
The role of aspirin, statins, colchicine, and IL-1 inhibitors in prevention of cardiovascular events: a systematic integrative review
Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?
Harms and Benefits of Using Aspirin for Primary Prevention of Cardiovascular Disease: A Narrative Overview
Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Japanese Patients with Atherosclerotic Risk Factors: Subanalysis of a Randomized Clinical Trial (JPPP-70)
Prevention of cardiovascular diseases
Investigating the effectiveness of different aspirin dosing regimens and the timing of aspirin intake in primary and secondary prevention of cardiovascular disease: protocol for a systematic review
Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer
Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the Management of Aspirin-induced Gastrointestinal Complications (MAGIC) study
Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
Aspirin for Prevention of Preeclampsia
The role of aspirin, statins, colchicine, and IL-1 inhibitors in prevention of cardiovascular events: a systematic integrative review
Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?
Harms and Benefits of Using Aspirin for Primary Prevention of Cardiovascular Disease: A Narrative Overview
Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Japanese Patients with Atherosclerotic Risk Factors: Subanalysis of a Randomized Clinical Trial (JPPP-70)
Prevention of cardiovascular diseases
Investigating the effectiveness of different aspirin dosing regimens and the timing of aspirin intake in primary and secondary prevention of cardiovascular disease: protocol for a systematic review
Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer